Skip to main content
Top

Journal of Thrombosis and Thrombolysis

Issue 1/2017

Content (19 Articles)

Dabigatran plasma levels, aPTT and thromboelastography in patients with AF: implications for allowing early non-elective surgical procedures

Athanasios Pipilis, Stamatis Makrygiannis, Georgios Anagnostou, Sotirios Kaliampakos, Georgios Tsakonas, Nikolaos Sourlas, Panagiotis Mallios, Theodora Kostelidou

Circulating microaggregates during cardiac surgery precedes postoperative stroke

Zühre Uz, Dan M. J. Milstein, Can Ince, Bastian A. J. M. de Mol

Pulmonary embolism response teams

Maya Serhal, Ihab S. Haddadin, Gustavo A. Heresi, Deborah A. Hornacek, Mehdi H. Shishehbor, John R. Bartholomew

Development of a predictive model for 6 month survival in patients with venous thromboembolism and solid malignancy requiring IVC filter placement

Steven Y. Huang, Bruno C. Odisio, Sharjeel H. Sabir, Joe E. Ensor, Andrew S. Niekamp, Tam T. Huynh, Michael Kroll, Sanjay Gupta

Time in therapeutic range as a marker for thrombotic and bleeding outcomes in Fontan patients

Jenna M. Faircloth, Kristin M. Miner, Tarek Alsaied, Nicole Nelson, Julie Ciambarella, Tomoyuki Mizuno, Joseph S. Palumbo, Alexander A. Vinks, Gruschen R. Veldtman

Essential thrombocythemia presenting as acute coronary syndrome: case reports and literature review

Nanqing Xiong, Wen Gao, Junjie Pan, Xinping Luo, Haiming Shi, Jian Li

Letter to the Editor

Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria

Marc Sorigue, Jordi Juncà, Elisa Orna, Nevena Romanic, Edurne Sarrate, Jordi Castellvi, Montse Soler, Ines Rodríguez-Hernandez, Evarist Feliu, Susana Ruiz

Perioperative bleeding and thrombotic risks in patients with Von Willebrand disease

Nathaniel R. Smilowitz, Navdeep Gupta, Yu Guo, Sripal Bangalore, Jeffrey S. Berger

Preemptive warfarin dose reduction after initiation of sulfamethoxazole-trimethoprim or metronidazole

Anna Powers, Erin B. Loesch, Anthony Weiland, Nicole Fioravanti, David Lucius

A systematic review of mobility/immobility in thromboembolism risk assessment models for hospitalized patients

Fan Ye, Carolyn Stalvey, Matheen A. Khuddus, David E. Winchester, Hale Z. Toklu, Joseph J. Mazza, Steven H. Yale

Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

Leonard L. L. Yeo, Tommy Andersson, Kong Wan Yee, Benjamin Y. Q. Tan, Prakash Paliwal, Anil Gopinathan, Mahendran Nadarajah, Eric Ting, Hock L. Teoh, Robin Cherian, Erik Lundström, Edgar L. W. Tay, Vijay K. Sharma

Open Access

Benefits and harms of 4-factor prothrombin complex concentrate for reversal of vitamin K antagonist associated bleeding: a systematic review and meta-analysis

Marjolein P. A. Brekelmans, Kim van Ginkel, Joost G. Daams, Barbara A. Hutten, Saskia Middeldorp, Michiel Coppens

Open Access

Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism

Abrar Ahmad, Kristina Sundquist, Bengt Zöller, Peter J. Svensson, Jan Sundquist, Ashfaque A. Memon

A novel fibrinogen variant: dysfibrinogenemia associated with γAsp185Asn substitution

Na Zhou, Peipei Xu, Min Zhou, Yong Xu, Ping Li, Bin Chen, Jian Ouyang, Rongfu Zhou

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.